Cefalexine [INN-French] en es it fr

Cefalexine [INN-French] Brand names, Cefalexine [INN-French] Analogs

Cefalexine [INN-French] Brand Names Mixture

  • No information avaliable

Cefalexine [INN-French] Chemical_Formula


Cefalexine [INN-French] RX_link


Cefalexine [INN-French] fda sheet

Cefalexine_[INN-French] FDA

Cefalexine [INN-French] msds (material safety sheet)

Cefalexine_[INN-French] MSDS

Cefalexine [INN-French] Synthesis Reference

R. B. Morin, B. G. Jackson, U.S. Pat. 3,275,626,861 (1966,1970)

Cefalexine [INN-French] Molecular Weight

347.39 g/mol

Cefalexine [INN-French] Melting Point


Cefalexine [INN-French] H2O Solubility

1789 mg/L

Cefalexine [INN-French] State


Cefalexine [INN-French] LogP


Cefalexine [INN-French] Dosage Forms

Capsules (containing cephalexin monohydrate equivalent to 250 mg or 500 mg cephalexin); Tablet (containing cephalexin monohydrate equivalent to 250 mg or 500 mg of cephalexin); Suspension

Cefalexine [INN-French] Indication

For the treatment of respiratory tract infections caused by Streptococcus pneumoniae and Streptococcus pyogenes; otitis media due to Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Moraxella catarrhalis; skin and skin structure infections caused by Staphylococcus aureus and/or Streptococcus pyogenes; bone infections caused by Staphylococcus aureus and/or Proteus mirabilis; genitourinary tract infections, including acute prostatitis, caused by Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae.

Cefalexine [INN-French] Pharmacology

Cephalexin (also called Cefalexin) is a first generation cephalosporin antibiotic. It is one of the most widely prescribed antibiotics, often used for the treatment of superficial infections that result as complications of minor wounds or lacerations. It is effective against most gram-positive bacteria.

Cefalexine [INN-French] Absorption

Well absorbed from the gastrointestinal tract

Cefalexine [INN-French] side effects and Toxicity

Symptoms of overdose include blood in the urine, diarrhea, nausea, upper abdominal pain, and vomiting. The oral median lethal dose of cephalexin in rats is >5000 mg/kg.

Cefalexine [INN-French] Patient Information

Patients should be counseled that antibacterial drugs including Keflex should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Keflex is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Keflex or other antibacterial drugs in the future.

Cefalexine [INN-French] Organisms Affected

Enteric bacteria and other eubacteria